Plus Therapeutics

Plus Therapeutics

Pharmaceuticals, 4200 Marathon BLVD, Austin, Texas, 78756, United States, 11-50 Employees

plustherapeutics.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: +12*********

Who is PLUS THERAPEUTICS

Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat...

Read More

map
  • 4200 Marathon BLVD, Austin, Texas, 78756, United States Headquarters: 4200 Marathon BLVD, Austin, Texas, 78756, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 446110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PLUS THERAPEUTICS

Plus Therapeutics Org Chart and Mapping

Employees

Ryan Kompare

Process Development Engineer I

Pius Maliakal

Vice President Clinical Ops

Daniel Ortega

Director, Chemistry,Manufacturing, and Controls

Oluwakemi Lawal

Senior Clinical Research Associate

Omar Algunaid

Manager, Drug Development and Production

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Plus Therapeutics

Answer: Plus Therapeutics's headquarters are located at 4200 Marathon BLVD, Austin, Texas, 78756, United States

Answer: Plus Therapeutics's phone number is +12*********

Answer: Plus Therapeutics's official website is https://plustherapeutics.com

Answer: Plus Therapeutics's revenue is $5 Million to $10 Million

Answer: Plus Therapeutics's SIC: 2834

Answer: Plus Therapeutics's NAICS: 446110

Answer: Plus Therapeutics has 11-50 employees

Answer: Plus Therapeutics is in Pharmaceuticals

Answer: Plus Therapeutics contact info: Phone number: +12********* Website: https://plustherapeutics.com

Answer: Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate, Rhenium-186 Nanoliposome, is being evaluated in the NIH-supported multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access